| Financial Year |
March 31 2023 |
| Monetary Funds |
7,724,041,427.15 |
| Held-for-trading Financial Assets |
1,858,958,167.16 |
| Notes Receivable |
41,877,739.61 |
| Accounts Receivable |
891,147,056.19 |
| Advances to Suppliers |
35,867,277.48 |
| Other Receivables |
19,029,594.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,704,891,447.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
223,767,537.07 |
| Total Current Assets |
14,555,030,854.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
22,093,348.13 |
| Long-term Equity Investment |
976,472,575.53 |
| Investment Properties |
6,517,055.43 |
| Fixed Assetes |
347,851,313.38 |
| Under-construction Projects |
1,062,029,791.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
567,145,298.90 |
| R&D expenses |
385,935,562.60 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,649,621.27 |
| Deferred Income Tax Assets |
56,967,324.64 |
| Other Non-Current Assets |
1,075,327,745.80 |
| Sub-Total of Non-Current Assets |
5,712,951,755.60 |
| Total Assets |
20,267,982,609.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
850,033,252.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,198,774.50 |
| Taxes Payable |
102,899,403.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
388,818,845.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,169,700.84 |
| Other Current Liabilities |
49,406,814.63 |
| Sub-Total of Current Liabilities |
3,850,015,305.85 |
| Long-term Loans |
500,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,623,916.08 |
| Deferred Income Tax Liabilities |
36,072,432.11 |
| Other Non-Current Liabilities |
1,254,660.00 |
| Sub-Total of Non-Current Liabilities |
605,142,016.78 |
| Total Liabilities |
4,455,157,322.63 |
| Paid-In Capital(Or Share Stock) |
616,244,480.00 |
| Capital Surplus |
12,697,636,739.33 |
| Surplus Reserve |
245,368,593.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,248,060,087.93 |
| Minority Stockholder's Interest |
-1,736,224.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,814,561,511.38 |
| Owner's Equity（Stockholder's Equity） |
15,812,825,287.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,267,982,609.73 |
